Serial measurements of acute phase proteins in patients with acute coronary syndrome

Hellenic Journal of Cardiology

Volumn 52, Issue 4, 2011, Pages 293-298

  Ziakas, Antonios G ^a   Koskinas, Konstantinos C ^a   Souliou, Efthimia ^a   Gavrilidis, Stavros ^a   Giannoglou, George D ^a   Gemitzis, Konstantinos ^a   Styliadis, Ioannis ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

Author keywords

Acute myocardial infarction; Inflammatory markers; Unstable angina

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA 1 ANTITRYPSIN; HAPTOGLOBIN; OROSOMUCOID;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MEASUREMENT; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

ACUTE CORONARY SYNDROME; ALPHA 1-ANTITRYPSIN; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; FEMALE; HAPTOGLOBINS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; OROSOMUCOID; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 79961154874     PISSN: 10117970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Libby P, Ridker PM. Inflammation and atherothrombosis. From population biology and bench research to clinical practice. J Am Coll Cardiol. 2006; 48: A33-46.
2. Libby P. The molecular mechanisms of the thrombotic complications of atherosclerosis. J Intern Med. 2008; 263: 517-527.
3. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342: 836-843.
4. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med. 2000; 343: 1139-1147.
5. Arant CB, Wessel TR, Ridker PM, et al. Multimarker approach predicts adverse cardiovascular events in women evaluated for suspected ischemia: results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation. Clin Cardiol. 2009; 32: 244-250.
6. Zairis MN, Manousakis SJ, Stefanidis AS, et al. C-reactive protein levels on admission are associated with response to thrombolysis and prognosis after ST-segment elevation acute myocardial infarction. Am Heart J. 2002; 144: 782-789.
7. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol. 2006; 109: 248-256.
8. Brunetti ND, Correale M, Pellegrino PL, Cuculo A, Biase MD. Acute phase proteins in patients with acute coronary syndrome: Correlations with diagnosis, clinical features, and angiographic findings. Eur J Intern Med. 2007; 18: 109-117.
9. Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J. 2000; 21: 1502-1513.
10. Smith SC Jr, Jacobs AK, Adams CD, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/ non ST-elevation myocardial infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction). Circulation. 2007; 116; e148-e304.
11. Miller YI, Altamentova SM, Shaklai N. Oxidation of lowdensity lipoprotein by hemoglobin stems from a heme-initiated globin radical: antioxidant role of haptoglobin. Biochemistry. 1997; 36: 12189-12198.
12. Moshage H. Cytokines and the hepatic acute phase response. J Pathol. 1997; 181: 257-266.
13. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448-454.
14. Hartford M, Wiklund O, Mattsson Hultén L, et al. CRP, interleukin- 6, secretory phospholipase A2 group IIA, and intercellular adhesion molecule-1 during the early phase of acute coronary syndromes and long-term follow-up. Int J Cardiol. 2006; 108: 55-62.
15. Crook M, Haq M, Haq S, Tutt P. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology. 1994; 45: 709-715.
16. Sánchez-Margalet V, Cubero JM, Martín-Romero C, Cubero J, Cruz-Fernández JM, Goberna R. Inflammatory response to coronary stent implantation in patients with unstable angina. Clin Chem Lab Med. 2002; 40: 769-774.
17. Zebrack JS, Anderson JL, Maycock CA, Horne BD, Bair TL, Muhlestein JB. Usefulness of high-sensitivity C-reactive protein in predicting long-term risk of death or acute myocardial infarction in patients with unstable or stable angina pectoris or acute myocardial infarction. Am J Cardiol. 2002; 89: 145-149.
18. Kaźmierczak E, Sobieska M, Kaźmierczak M, Mrozikiewicz A, Wiktorowicz K. Intense acute phase response in ischemic patients. Int J Cardiol. 1999; 68: 69-73.
19. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 2002; 39: 1917-1923.
20. Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes. Clin Chim Acta. 2007; 376: 168-173.
21. Werner N, Nickenig G, Laufs U. Pleiotropic effects of HMGCoA reductase inhibitors. Basic Res Cardiol. 2002; 97: 105-116.
22. Kinlay S, Schwartz GG, Olsson AG, et al. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation. 2003; 108: 1560-1566.
23. Papageorgiou N, Tousoulis D, Antoniades C, Giolis A, Briasoulis A, Stefanadis C. The impact of statin administration in acute coronary syndromes. Hellenic J Cardiol. 2010; 51: 250-261.
24. Ziakas A, Gavrilidis S, Giannoglou G, et al. In-hospital and long-term prognostic value of fibrinogen, CRP, and IL-6 levels in patients with acute myocardial infarction treated with thrombolysis. Angiology. 2006; 57: 283-293.
25. Ziakas A, Gavrilidis S, Giannoglou G, et al. Kinetics and prognostic value of inflammatory-sensitive protein, IL-6, and white blood cell levels in patients undergoing coronary stent implantation. Med Sci Monit. 2009; 15: CR177-184.